Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The purpose is to evaluate efficacy and safety of therapeutic hepatitis B virus (HBV) vaccine
(mimogen-based)) Joint entecavir treatment in chronic hepatitis B patients.